Pediatrix Medical (MD) Capital Expenditures (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Capital Expenditures data on file, last reported at $6.2 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $6.2 million, up 88.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (up 818.95% YoY), and the FY2025 annual result was $1.5 million, up 5.07% from the prior year.
• Capital Expenditures climbed to $6.2 million in Q1 2026 per MD's latest filing, from -$11.7 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $9.2 million in Q3 2023 and troughed at -$17.2 million in Q4 2024.
• A 5-year average of $4.2 million and a median of $6.6 million in 2022 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures soared 133.82% in 2022, then sank 289.98% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $9.1 million in 2022, then retreated by 0.15% to $9.0 million in 2023, then slumped by 289.98% to -$17.2 million in 2024, then surged by 31.91% to -$11.7 million in 2025, then soared by 153.39% to $6.2 million in 2026.
• Business Quant data shows MD's Capital Expenditures at $6.2 million in Q1 2026, -$11.7 million in Q4 2025, and $5.3 million in Q3 2025.